Core Evidence
Published by Dove Medical Press
ISSN : 1555-1741 eISSN : 1555-175X
Abbreviation : Core Évid.
Aims & Scope
Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch.
The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups.
The journal encourages the submission of unsolicited review articles.
View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.